Stock Information
BridgeBio Pharma Inc (BBIO)
Ticker Symbol: BBIO
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $12,811.28 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -3.7841
Revenue (TTM): $2.59 M
Dividend Yield: N/A%
ROE: -206.74%
Latest News
-
BridgeBio to Present Long-Term Efficacy and Safety Data from the ATTRibute-CM OLE Trial at the ACC Annual Scientific Sessions
Mon, Mar 23, 2026 11:30 AM
-
BridgeBio Pharma To Share Long-Term Efficacy, Safety Data In Participants With ATTR-CM From Its Phase 3 Trial Of Acoramidis At American College of Cardiology Annual Scientific Sessions & Expo
Mon, Mar 23, 2026 7:37 AM
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Fri, Mar 20, 2026 8:01 PM
-
Can Alnylam's Pipeline Drugs Sustain Long-Term Growth Ahead?
Thu, Mar 19, 2026 2:33 PM
-
Mizuho Maintains Outperform on BridgeBio Pharma, Raises Price Target to $106
Wed, Mar 18, 2026 1:52 PM
Key Financials
Financial data not available
